Publication | Closed Access

Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study

Opioid EpidemicOncologyPhase Ii TrialPain MedicineMedicineCancer PainAddiction MedicinePharmacotherapyPain ManagementCancer PatientsPharmacologySubcutaneous MethylnaltrexoneOpioid Use DisorderAnesthesiologyHealth Sciences